Teva Branded Pharmaceutical Products R&D, Inc.
Teva Branded Pharmaceutical Products R&D, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., is a leading player in the global pharmaceutical industry, headquartered in the United States. Founded in 1901, Teva has established itself as a pioneer in the development and manufacturing of generic and specialty medicines, with a strong focus on therapeutic areas such as central nervous system disorders, respiratory conditions, and oncology.
With major operational regions across North America, Europe, and beyond, Teva is renowned for its extensive portfolio of high-quality medications. The company’s commitment to innovation is evident in its robust research and development efforts, which have led to numerous key milestones, including the launch of several groundbreaking treatments. Teva's unique approach to drug development and its market position as one of the largest generic drug manufacturers underscore its significant contributions to improving patient outcomes worldwide.
+47 vs industry average
Teva Branded Pharmaceutical Products R&D, Inc.’s score of 85 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Teva Branded Pharmaceutical Products R&D, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Teva Branded Pharmaceutical Products R&D, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Teva Branded Pharmaceutical Products R&D, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Teva Branded Pharmaceutical Products R&D, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Teva Pharmaceutical Industries Limited
Carbon Disclosure Project
Inherited from Teva Pharmaceutical Industries LimitedThe Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project